AzTrials
AzTrials

AnesthesiaTUGGERNCT06527352

Risk of Gastric Reflux During Tulip vs GMA(Glottis Mask Airway) Airway

A study testing glottis mask airway, tulip shaped and classical shaped in people with Anesthesia, run by Air Force Military Medical University, China at 1 site in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Glottis mask airway (GMA) is supraglottic airway device and is frequently used in patients undergoing general anesthesia. However, gastroesophageal reflux remains a risk during ventilation through supraglottic airway devices. The classical shaped GMA and tulip shaped GMA differ in the shape of their tips. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Anesthesia
What is being tested?
glottis mask airway, tulip shaped and classical shaped
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
72 participants
Where
1 siteChina
Study dates
1 Aug 2024to 29 Jan 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • age≥18 years old
  • scheduled for surgery under general anesthesia with laryngeal mask airway

Who cannot join

  • American society of anesthesiologists status score higher than 3
  • morbid obesity (body mass index higher than 40 kg/m2)
  • with high risk of gastroesophageal reflux
  • with risk of difficult airway
  • with airway disease

Trial locations and contacts

1 site in 1 country.

China1 site
  • Xijing Hospital, Air Force Medical University

    Xi'an, Shaanxi, 710032

Other trials in China

About this study

Official title: Comparison of Risk of Gastroesophageal Reflux During General Anesthesia With Tulip vs GMA(Glottis Mask Airway) Airway

Glottis mask airway (GMA) is supraglottic airway device and is frequently used in patients undergoing general anesthesia. However, gastroesophageal reflux remains a risk during ventilation through supraglottic airway devices. The classical shaped GMA and tulip shaped GMA differ in the shape of their tips. And theoretically the tulip shaped tip fits the larynx better. This study aims to compare the incidence of gastroesophageal reflux during ventilation through classical shaped vs tulip shaped glottis mask airway.

Conditions
Anesthesia
Being tested
glottis mask airway, tulip shaped, classical shaped
Keywords
general anesthesia, glottis mask airway, Tulip shaped tip, gastroesophageal reflux
Medical subject headings
Gastroesophageal Reflux

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • glottis mask airwayDevice

    the glottis mask airway is used for maintaining ventilation during general anesthesia

  • tulip shapedOther

    the tulip shaped mask airway is with a tulip shaped tip

  • classical shapedOther

    the classical shaped mask airway is with a water-drop shaped tip

Study groups in NCT06527352
Study groupRoleWhat they receive
classical shaped mask airwayOtherNot described
Receives: Device: glottis mask airway; Other: classical shaped
tulip shaped mask airwayOtherNot described
Receives: Device: glottis mask airway; Other: tulip shaped

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. pH value of secretion on the tip of glottis mask airway at the end of surgery

    Measured: at the end of surgery

Secondary outcomes (11)
  1. number of participants with a pH value of secretion on the tip of glottis mask airway less than 4.1

    Measured: at the end of surgery

  2. Oropharyngeal leak pressure

    Oropharyngeal leak pressure (OLP) was measured by setting the adjustable pressure limiting valve to 40 cmH2O at a fixed gas flow of 3 L/min and noting the steady-state airway pressure on the monitor

    Measured: from insertion of glottis mask airway to start of surgery, at an average of 10 minutes

  3. duration of inserting glottis mask airway

    Measured: from taking of glottis mask airway to inserting it to appropriate position, at an average of 1 minute

  4. number of insertion to achieve successful positioning of glottis mask airway

    Measured: from taking of glottis mask airway to inserting it to appropriate position, at an average of 1 minute

  5. duration of establishing appropriate ventilation

    Measured: from taking of glottis mask airway to inserting it to appropriate position, at an average of 1 minute

  6. incidence of epiglottis suppression

    Measured: from insertion of glottis mask airway to start of surgery, at an average of 10 minutes

  7. number of needs for modulating the position of glottis airway mask during surgery

    Measured: from insertion of glottis mask airway to end of surgery, at an average of 2 hours

  8. scale of difficulty of inserting gastric tube

    0 is for easy to insert; 1 is for a little difficult to insert; 2 is for fail to insert

    Measured: from insertion of glottis mask airway to start of surgery, at an average of 10 minutes

  9. incidence of blood on the tip of glottis airway mask

    Measured: from end of surgery to withdrawal of glottis airway mask, at an average of 5 minutes

  10. score of satisfaction of anesthesiologist to glottis airway mask

    the score is from 0 to 10, a higher score means higher satisfaction

    Measured: from insertion of glottis mask airway to withdrawal of glottis airway mask, at an average of 2 hours

  11. incidence of glottis airway mask related adverse events by 24 hours after surgery

    the glottis airway mask related adverse events include laryngeal pain, horse and dysphonia

    Measured: 24 hours after surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Jul 2024
  2. Study start1 Aug 2024
  3. Primary completion28 Jan 2025
  4. Study completion29 Jan 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
72 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06527352
Sponsor's protocol ID
XJH-A-20240708
Acronym
TUGGER
Status last verified
Jan 2026
First submitted
25 Jul 2024
Last updated
6 Jan 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Lemos J, De Oliveira GS Jr, de Pereira Cardoso HE, Lemos LD, de Carvalho LR, Modolo NS. Gastric regurgitation in patients undergoing gynecological laparoscopy with a laryngeal mask airway: a prospective observational study. J Clin Anesth. 2017 Feb;36:32-35. doi: 10.1016/j.jclinane.2016.07.038. Epub 2016 Nov 11.

    PubMed 28183569
  • Nakanishi T, Sakamoto S, Yoshimura M, Toriumi T. AutoFlow(R) versus volume-controlled ventilation for laparoscopic gynecological surgery using LMA(R) ProSeal: a randomized controlled trial. BMC Anesthesiol. 2021 Jun 28;21(1):181. doi: 10.1186/s12871-021-01406-6.

    PubMed 34182933
  • Liu Y, Song Y, Wang M, Yang M, Shen H, Wang Z, Chen L, Yang J, Gong S, Yu Y, Shi Z, Zhang W, Zou X, Sun X, Wang Y, Fu Q, Cao J, Mi W. LMA(R) protector in patients undergoing laparoscopic surgeries: a multicenter prospective observational study. BMC Anesthesiol. 2021 Dec 20;21(1):318. doi: 10.1186/s12871-021-01535-y.

    PubMed 34930137
  • Bhardwaj M, Dhania S, Kaur K, Lal J, Priya, Singhal SK. Comparison of oropharyngeal leak pressure of LMA Protector and LMA ProSeal in anaesthetised paralysed patients - A randomised controlled trial. Indian J Anaesth. 2023 Nov;67(Suppl 4):S245-S250. doi: 10.4103/ija.ija_403_23. Epub 2023 Nov 21.

    PubMed 38187973
  • Wang Y, Qu K, Tuo X, Wang F, Wang Y, Qi Y, Lu Z. Tulip-shaped vs. classic gel supraglottic airway device on hypopharyngeal secretion pH: a randomised clinical trial. Open Med (Wars). 2026 Nov 2;21(1):20261535. doi: 10.1515/med-2026-1535. eCollection 2026 Jan.

    PubMed 42974115

Questions about this trial

What is this clinical trial studying?

A study testing glottis mask airway, tulip shaped and classical shaped in people with Anesthesia, run by Air Force Military Medical University, China at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

pH value of secretion on the tip of glottis mask airway at the end of surgery (time frame: at the end of surgery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06527352, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Jan 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in